ATE500336T1 - Expression von schutzantigenen in transgenen chloroplasten und herstellung verbesserter impfstoffe - Google Patents

Expression von schutzantigenen in transgenen chloroplasten und herstellung verbesserter impfstoffe

Info

Publication number
ATE500336T1
ATE500336T1 AT02792531T AT02792531T ATE500336T1 AT E500336 T1 ATE500336 T1 AT E500336T1 AT 02792531 T AT02792531 T AT 02792531T AT 02792531 T AT02792531 T AT 02792531T AT E500336 T1 ATE500336 T1 AT E500336T1
Authority
AT
Austria
Prior art keywords
vaccines
well
plants
protective antigens
expression
Prior art date
Application number
AT02792531T
Other languages
English (en)
Inventor
Henry Daniell
Original Assignee
Univ Central Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Central Florida filed Critical Univ Central Florida
Application granted granted Critical
Publication of ATE500336T1 publication Critical patent/ATE500336T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A61N1/0565—Electrode heads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02792531T 2001-12-26 2002-12-26 Expression von schutzantigenen in transgenen chloroplasten und herstellung verbesserter impfstoffe ATE500336T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34470401P 2001-12-26 2001-12-26
US39365102P 2002-07-03 2002-07-03
US40081602P 2002-08-02 2002-08-02
PCT/US2002/041503 WO2003057834A2 (en) 2001-12-26 2002-12-26 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines

Publications (1)

Publication Number Publication Date
ATE500336T1 true ATE500336T1 (de) 2011-03-15

Family

ID=27407646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02792531T ATE500336T1 (de) 2001-12-26 2002-12-26 Expression von schutzantigenen in transgenen chloroplasten und herstellung verbesserter impfstoffe

Country Status (6)

Country Link
EP (2) EP1456390B1 (de)
AT (1) ATE500336T1 (de)
AU (1) AU2002358292B2 (de)
CA (1) CA2471737C (de)
DE (1) DE60239355D1 (de)
WO (1) WO2003057834A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110179530A1 (en) * 2001-01-23 2011-07-21 University Of Central Florida Research Foundation, Inc. Pharmaceutical Proteins, Human Therapeutics, Human Serum Albumin Insulin, Native Cholera Toxin B Subunit on Transgenic Plastids
US20100251425A9 (en) 1998-05-15 2010-09-30 University Of Central Florida Expression of human interferon in transgenic chloroplasts
EP1274846A4 (de) 2000-03-01 2004-09-29 Univ Auburn Plastidentransformationsvektoren für die expression von menschlichen proteinen in pflanzen
CA2491690C (en) 2002-07-03 2016-10-18 University Of Central Florida Somatogenic plastid transformation
CN1833030B (zh) 2003-05-22 2014-07-23 美国弗劳恩霍夫股份有限公司 用于表达、传递及纯化目标多肽的重组载体分子
WO2005086667A2 (en) * 2004-02-27 2005-09-22 The Dow Chemical Company High efficiency peptide production in plant cells
BRPI0610243A2 (pt) * 2005-05-27 2010-06-08 Univ Central Florida Res Found vacina produzida de planta contra amebìase
US20080274143A1 (en) * 2005-05-27 2008-11-06 Henry Daniell Chloroplasts Engineering to Express Pharmaceutical Proteins
US20180371485A1 (en) * 2005-05-27 2018-12-27 The Trustees Of The University Of Pennsylvania Chloroplasts engineered to express pharmaceutical proteins
EP1919504B1 (de) 2005-08-03 2013-10-16 iBio, Inc. Antikörper gegen bacillus anthracis protektiv antigen
GB2447416B (en) * 2006-12-15 2010-08-25 Uni I Stavanger Methods and vectors for transformation of plastids and marker excision using site-specific recombination
AU2008232543B2 (en) 2007-03-30 2013-01-17 University Of Central Florida Research Foundation, Inc. Chloroplasts engineered to express pharmaceutical proteins in edible plants
US8404252B2 (en) 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
BRPI0818268A2 (pt) * 2007-10-31 2017-05-09 Univ Central Florida Res Found Inc antígenos de vacina humana derivados de cloroplasto contra a malária
US20100266640A1 (en) * 2009-04-20 2010-10-21 Henry Daniell Plant-Derived Cholera and Malaria Vaccine
US10689633B2 (en) 2008-02-29 2020-06-23 The Trustees Of The University Of Pennsylvania Expression of β-mannanase in chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
US9724400B2 (en) 2009-11-09 2017-08-08 The Trustees Of The University Of Pennsylvania Administration of plant expressed oral tolerance agents
US10865419B2 (en) 2011-10-24 2020-12-15 The Trustees Of The University Of Pennsylvania Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
EP2771469A4 (de) * 2011-10-24 2015-04-08 Univ Central Florida Res Found An choleratoxin-b-untereinheit kondeniserte plastid-exprimierte mycobacterium-tuberkuloseimpfstoffantigene esat-6 und mtb72f
CN104004696A (zh) * 2013-02-27 2014-08-27 中国人民解放军军事医学科学院生物工程研究所 一株ba5641基因缺失的炭疽杆菌及其构建方法
EP3058074B1 (de) 2013-10-18 2019-02-20 Trustees Of The University Of Pennsylvania Orale verabreichung des angiotensin-konvertierenden enzyms 2 (ace2) oder von in pflanzenzellen biogekapseltem angiotensin-(1-7)
HRP20201680T1 (hr) 2013-11-15 2021-03-19 The Trustees Of The University Of Pennsylvania Pripravci za suzbijanje nastajanja inhibitora protiv faktora viii kod pacijenata sa hemofilijom a
US20180327768A1 (en) 2015-11-16 2018-11-15 The Trustees Of The University Of Pennsylvania Targeted delivery of therapeutic proteins bioencapsulated in plant cells to cell types of interest for the treatment of disease
US20230126093A1 (en) * 2020-03-16 2023-04-27 Vrije Universiteit Brussel Synthetic dna template for in vitro mrna transcription

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
US5932479A (en) 1988-09-26 1999-08-03 Auburn University Genetic engineering of plant chloroplasts
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
WO1999010513A1 (en) * 1997-08-07 1999-03-04 Auburn University Universal chloroplast integration and expression vectors, transformed plants and products thereof
MXPA01000372A (es) * 1998-07-10 2002-10-17 Calgene Llc Expresion de genes de tolerancia a herbicidas en plastidos de plantas.
WO2001064024A1 (en) 2000-02-29 2001-09-07 Auburn University Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants
EP1274846A4 (de) * 2000-03-01 2004-09-29 Univ Auburn Plastidentransformationsvektoren für die expression von menschlichen proteinen in pflanzen
AU2001245359A1 (en) 2000-03-02 2001-09-12 Auburn University Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection

Also Published As

Publication number Publication date
AU2002358292B2 (en) 2008-12-18
WO2003057834A2 (en) 2003-07-17
DE60239355D1 (de) 2011-04-14
EP2284274A1 (de) 2011-02-16
EP1456390B1 (de) 2011-03-02
AU2002358292A1 (en) 2003-07-24
EP2284274B1 (de) 2015-08-26
EP1456390A2 (de) 2004-09-15
EP1456390A4 (de) 2005-12-21
CA2471737A1 (en) 2003-07-17
CA2471737C (en) 2016-01-26
WO2003057834A3 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
DE60239355D1 (de) Expression von schutzantigenen in transgenen chloroplasten und herstellung verbesserter impfstoffe
BR0116026A (pt) Imidazoquinolinas substituìdas por tioéter
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
WO2003084477A3 (en) Mammalian cdr mimetibodies, compositions, methods and uses
ATE272410T1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
DK1427828T3 (da) Tilfældig integration af et polynucleotid efter in vivo-linearisering
DE60014076D1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
BR0016460A (pt) Construções de expressão de planta novas
EP1375668A4 (de) Pflanzenwachstumsspezifischer promotor und damit erhaltene genetisch modifizierte pflanzen
EP2261364A3 (de) Für die Expression pharmazeutischer Proteine entwickelte Chloroplaste
AR051018A1 (es) Cepas agrobacterium desarmadas, ri-plasmidos, y metodos de transformacion basados en los mismos
AR072797A2 (es) Construccion de adn, su uso para el control de la expresion genetica en plantas y metodo para obtener una planta transgenica
WO2006016380A3 (en) A chimeric g protein based rabies vaccine
DE60037983D1 (de) Verfahren zur Transformation reifer Eukalyptusbäume
EP1451301A4 (de) Förderung der somatischen embryogenese in pflanzen durch wuschel-genexpression
BR0215273A (pt) Proteìnas, genes da ciclopropano ácido graxo sintase de plantas e seus usos
YU221690A (sh) Transgenetske biljke koje pripadaju vrsti cucumis melo
EP1294221A4 (de) Markerfreie transgene pflanzen: manipulierung des chloroplastengenoms ohne antibiotikaselektion
AU2003265960A8 (en) Method of preparing amino acid taxane derivatives and polymer conjugates containing the same
ATE547116T1 (de) Kombinationsimpfstoff
AR060182A1 (es) Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion
WO2002094008A3 (en) Transgenic plants protected against parasitic plants
ATE547526T1 (de) Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen
ATE342369T1 (de) Herstellung transgener pflanzen der gattung tagetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties